BALFX
Price
$41.06
Change
+$0.10 (+0.24%)
Updated
Jun 2 closing price
Net Assets
278.87B
POICX
Price
$10.15
Change
-$0.01 (-0.10%)
Updated
Jun 2 closing price
Net Assets
577.43M
Interact to see
Advertisement

BALFX vs POICX

Header iconBALFX vs POICX Comparison
Open Charts BALFX vs POICXBanner chart's image
BALFX vs POICX Comparison Chart in %
View a ticker or compare two or three
VS
BALFX vs. POICX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BALFX is a Hold and POICX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
BALFX has more cash in the bank: 279B vs. POICX (577M). BALFX pays higher dividends than POICX: BALFX (1.75) vs POICX (1.43). BALFX was incepted earlier than POICX: BALFX (25 years) vs POICX (27 years). POICX (1.88) is less costly to investors than BALFX (0.61). BALFX is a more actively managed with annual turnover of: 50.00 vs. POICX (46.00). BALFX has a lower initial minimum investment than POICX: BALFX (250) vs POICX (2500). BALFX annual gain was more profitable for investors over the last year : 17.70 vs. POICX (-9.24). BALFX return over 5 years is better than : 35.27 vs. POICX (-22.41).
BALFXPOICXBALFX / POICX
Total Expense Ratio0.611.7535%
Annual Report Gross Expense Ratio0.611.8832%
Fund Existence25 years27 years-
Gain YTD9.6731.516638%
Front LoadN/AN/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets279B577M48,354%
Annual Yield % from dividends1.751.43122%
Returns for 1 year17.70-9.24-192%
Returns for 3 years45.435.78786%
Returns for 5 years35.27-22.41-157%
Returns for 10 years85.7922.24386%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BLK1018.96-1.77
-0.17%
Blackrock
HIMS27.51-0.25
-0.90%
Hims & Hers Health
TV2.64-0.03
-1.12%
Grupo Televisa SA
CAN0.39-0.01
-3.36%
Canaan
MDXH0.63-0.03
-4.21%
MDxHealth SA